Table of Contents
Lung Cancer International
Volume 2015 (2015), Article ID 317868, 6 pages
http://dx.doi.org/10.1155/2015/317868
Research Article

Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden

1Department of Respiratory Medicine, Gävle Hospital, 80187 Gävle, Sweden
2Karolinska Institutet, Stockholm, Sweden
3Centre for Research and Development, Uppsala University, County Council of Gävleborg, Gävle, Sweden
4Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Solna, Stockholm, Sweden

Received 30 April 2015; Revised 25 June 2015; Accepted 28 June 2015

Academic Editor: Giovanni Luca Ceresoli

Copyright © 2015 Hirsh Koyi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent et al., “Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012,” European Journal of Cancer, vol. 49, no. 6, pp. 1374–1403, 2013. View at Google Scholar · View at Scopus
  2. M. Mistry, D. M. Parkin, A. S. Ahmad, and P. Sasieni, “Cancer incidence in the United Kingdom: projections to the year 2030,” British Journal of Cancer, vol. 105, no. 11, pp. 1795–1803, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. K. Owonikoko, C. C. Ragin, C. P. Belani et al., “Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database,” Journal of Clinical Oncology, vol. 25, no. 35, pp. 5570–5577, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Hoffe and L. Balducci, “Cancer and age: general considerations,” Clinics in Geriatric Medicine, vol. 28, no. 1, pp. 1–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. H. K. Weir, T. D. Thompson, A. Soman, B. Møller, and S. Leadbetter, “The past, present, and future of cancer incidence in the United States: 1975 through 2020,” Cancer, vol. 121, pp. 1827–1837, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Gridelli, L. Balducci, F. Ciardiello et al., “Treatment of elderly patients with non-small cell lung cancer: results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology,” Clinical Lung Cancer, 2015. View at Publisher · View at Google Scholar
  7. J. Piquet, F. Blanchon, M. Grivaux et al., “Primary bronchial carcinoma in elderly subjects in France,” Revue des Maladies Respiratoires, vol. 20, no. 5, pp. 691–699, 2003. View at Google Scholar · View at Scopus
  8. The Elderly Lung Cancer Vinorelbine Italian Study Group, “Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer,” Journal of the National Cancer Institute, vol. 91, no. 1, pp. 66–72, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Gridelli, F. Perrone, C. Gallo et al., “Chemotherapy for elderly patients with advanced non small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial,” Journal of the National Cancer Institute, vol. 95, no. 5, pp. 362–372, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. C. Denson and A. Mahipal, “Participation of the elderly population in clinical trials: barriers and solutions,” Cancer Control, vol. 21, no. 3, pp. 209–214, 2014. View at Google Scholar · View at Scopus
  11. J. H. Lewis, M. L. Kilgore, D. P. Goldman et al., “Participation of patients 65 years of age or older in cancer clinical trials,” Journal of Clinical Oncology, vol. 21, no. 7, pp. 1383–1389, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Hotta, H. Ueoka, K. Kiura, M. Tabata, and M. Tanimoto, “An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer,” Lung Cancer, vol. 46, no. 1, pp. 61–76, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Gridelli, C. Langer, P. Maione, A. Rossi, and S. E. Schild, “Lung cancer in the elderly,” Journal of Clinical Oncology, vol. 25, no. 14, pp. 1898–1907, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. F. Mountain, “A new international staging system for lung cancer,” Chest, vol. 89, no. 4, pp. 225S–233S, 1986. View at Google Scholar · View at Scopus
  15. M. E. Charlson, P. Pompei, K. L. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Balducci, “Geriatric oncology,” Critical Reviews in Oncology/Hematology, vol. 46, pp. 211–220, 2003. View at Google Scholar
  17. P. J. Hesketh, R. Lilenbaum, K. Chansky et al., “Chemotherapy in patients 80 with advanced non-small cell lung cancer. Combined results from SWOG 0027 and LUN 6,” Journal of Clinical Oncology, vol. 23, abstract 7147, p. 657, 2005. View at Google Scholar
  18. W. M. Alberts, “American College of Chest Physicians. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition),” Chest, vol. 132, supplement 3, pp. 1S–19S, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Frasci, V. Lorusso, N. Panza et al., “Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 18, no. 13, pp. 2529–2536, 2000. View at Google Scholar · View at Scopus
  20. C. Gridelli, F. Perrone, C. Gallo et al., “Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the multicenter Italian lung cancer in the elderly study (MILES) phase III randomized trial,” Journal of the National Cancer Institute, vol. 95, no. 5, pp. 362–372, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Kudoh, K. Takeda, K. Nakagawa et al., “Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group trial (WJTOG 9904),” Journal of Clinical Oncology, vol. 24, no. 22, pp. 3657–3663, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. E. A. Quoix, J. Oster, V. Westeel et al., “Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC),” Journal of Clinical Oncology, vol. 28, supplement 18, abstract 2, 2010. View at Google Scholar
  23. J. H. Schiller, D. Harrington, C. P. Belani et al., “Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer,” The New England Journal of Medicine, vol. 346, no. 2, pp. 92–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. A. J. Davidoff, M. Tang, B. Seal, and M. J. Edelman, “Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 28, no. 13, pp. 2191–2197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. J. Davidoff, M. Tang, B. Seal, and M. J. Edelman, “Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer,” The Cancer Journal, vol. 28, pp. 2191–2197, 2010. View at Google Scholar
  26. L. F. Hutchins, J. M. Unger, J. J. Crowley, C. A. Coltman Jr., and K. S. Albain, “Underrepresentation of patients 65 years of age or older in cancer-treatment trials,” The New England Journal of Medicine, vol. 341, no. 27, pp. 2061–2067, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Quoix, I. Monnet, P. Scheid et al., “Management and outcome of French elderly patients with lung cancer: an IFCT survey,” Revue des Maladies Respiratoires, vol. 27, no. 5, pp. 421–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. J. Hesketh, R. C. Lilenbaum, K. Chansky et al., “Chemotherapy in patients 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6,” Journal of Thoracic Oncology, vol. 2, no. 6, pp. 494–498, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. K. S. Albain, J. J. Crowley, M. LeBlanc, and R. B. Livingston, “Survival determinants in extensive-stage non-small-cell lung cancer: the southwest oncology group experience,” Journal of Clinical Oncology, vol. 9, no. 9, pp. 1618–1626, 1991. View at Google Scholar · View at Scopus
  30. D. Clement, L. Miron, and M. Marinca, “Age-related prognostic factors and treatment results for advanced non-small cell lung cancer (NSCLC),” Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi, vol. 111, no. 4, pp. 856–863, 2007. View at Google Scholar
  31. R. H. Ansari, M. A. Socinski, M. J. Edelman et al., “A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer,” Critical Reviews in Oncology/Hematology, vol. 78, no. 2, pp. 162–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Quoix, G. Zalcman, J.-P. Oster et al., “Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial,” The Lancet, vol. 378, no. 9796, pp. 1079–1088, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. T. R. Asmis, K. Ding, L. Seymour et al., “Age and comorbidity as independent prognostic factors in the treatment of non-small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group Trials,” Journal of Clinical Oncology, vol. 26, no. 1, pp. 54–59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Altundag, D. J. Stewart, F. V. Fossella et al., “Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy,” Journal of Thoracic Oncology, vol. 2, no. 2, pp. 141–146, 2007. View at Google Scholar · View at Scopus
  35. T. Kawaguchi, M. Takada, A. Kubo et al., “Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in japan,” Journal of Thoracic Oncology, vol. 5, no. 7, pp. 1011–1017, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Sun, J. H. Schiller, and A. F. Gazdar, “Lung cancer in never smokers—a different disease,” Nature Reviews Cancer, vol. 7, no. 10, pp. 778–790, 2007. View at Publisher · View at Google Scholar · View at Scopus